Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000632037 | SCV000753140 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-10-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001190263 | SCV001357714 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-01-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002222566 | SCV002500504 | likely benign | not specified | 2022-03-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003820 | SCV004814731 | likely benign | Marfan syndrome | 2023-06-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001190263 | SCV005032431 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-11-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |